Emergent decision-making: defining the patient perspective.
Knudtson
Merril L
ML
D015906:Angioplasty, Balloon, Coronary; D005343:Fibrinolytic Agents / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy*; D015425:Myocardial Reperfusion / Q000191:economics / Q000379:methods*; D009864:Ontario; D017060:Patient Satisfaction; D012307:Risk Factors; D013300:Streptokinase / Q000191:economics / Q000627:therapeutic use; D020521:Stroke / Q000517:prevention & control; D015912:Thrombolytic Therapy / Q000191:economics; D010959:Tissue Plasminogen Activator / Q000191:economics / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D013300:Streptokinase; D010959:Tissue Plasminogen Activator